PREVIEW
According to current estimates, more than 12 million people in the United States have coronary artery disease (CAD). Slightly less than half experience angina pectoris, and more than 7 million have had a myocardial infarction.1 In 2000, the economic cost of CAD in this country totaled $118 billion.1 Given the aging of the population and the improved therapy for several other disorders, a true epidemic looms on the horizon. In this article, Dr Bales examines the long-term medical treatment of patients with known ischemic heart disease, focusing on therapies proven to alter morbidity and mortality, relieve symptoms, and modify risk factors.